Biohaven Pharma (BHVN) Announces up to $500 Million Non-Dilutive Term Loan with Sixth Street

Go back to Biohaven Pharma (BHVN) Announces up to $500 Million Non-Dilutive Term Loan with Sixth Street

Biohaven Pharma (BHVN) Tops Q2 EPS by 6c, Revenues Beat

August 10, 2020 7:47 AM EDT

Biohaven Pharma (NYSE: BHVN) reported Q2 EPS of ($2.55), $0.06 better than the analyst estimate of ($2.61). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $7.65 million.

Vlad Coric, M.D. Chief Executive Officer, commented, "This has been an... More